Best Practice | > About >Best Practice |
Table of Contents
1. Website
The URL address of official journal web site is https://www.medhist.or.kr/.
Aims & Scope statement: https://www.medhist.or.kr/about/
The Korean Journal of Medical History (KJMH) is the peer-reviewed, open-access official journal of the KOREAN society for the History of Medicine. It began to be published from 1992. It had been published biannually from 1992 to 2011. It is published tri-annually in the last day of April, August and December from 2012. Its scope includes historical research not only on Korea, but also on East Asia and Western countries. It accepts manuscripts from ancient history to modern history in the field of medicine, dentistry, nursing, and oriental medicine. Its abbreviated title is the Korean J Med Hist. Circulation number of print copies per issue is 550.
Readership:
The Korean Journal of Medical History includes historical research not only on Korea, but also on East Asia and Western countries. It accepts manuscripts from ancient history to modern history in the field of medicine, dentistry, nursing, and oriental medicine.
Authorship criteria: https://www.medhist.or.kr/authors/authors.php
The practices of Korean Journal of Medical History regarding research and publication ethics strictly follow the International Committee of Medical Journal Editors (ICMJE) guidelines (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html), which state that authorship credit should be based on all of the following: 1) substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; 2) drafting the work or revising it critically for important intellectual content; 3) final approval of the version to be published; 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All other contributors should be credited in the acknowledgments. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained in a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author.
ISSN Information: pISSN: 1225-505X, eISSN: 2093-5609
2. Name of journal
The official journal title is Korean Journal of Medical History. Abbreviated title is Korean J Med Hist.
3. Peer review process
https://www.medhist.or.kr/authors/authors.php
Type of peer review: Double-blind review
(1) The editorial board reviews the suitability of topic, contents, and style of the submitted article by appointing three editors to review the article.
(2) The editors shall make one of the following decisions after examining the article according to its topic, contents, and style, as based on the guidelines of the review criteria: publication (A); publication with correction (B); re-submission after amendment (C); and reject (D).
(3) The editors shall clearly and precisely describe the reasons for C and D decisions.
(4) The editorial board summarizes the editors’ decisions and makes final judgments according to the following principle.
AAA·AAB: Publication
AAC·ABB·ABC·BBB·BBC: Publication with Correction
AAD·ABD·ACD·ACC·BBD·BCC·CCC: Re-submission after
Amendment
ADD·BCD·BDD·CCD·CDD·DDD: Reject
(5) If the article is rejected for publication, the author can request a re‐examination with reasonable arguments against the editors’ decisions. If the editorial board holds that the re‐examination request is reasonable, it can ask other editors to review the article. However, the author cannot further argue against the results of re-examination.
(6) The editorial board will determine the publication of book reviews and introduction to materials.
(7) When providing review requests and decisions, the editorial board makes the authors and editors anonymous.
(8) The authors should respect the editors’ decisions of amendment.
4. Ownership, journal management team, and publishing credentials
The journal is owned by the publisher, the Korean Society for the History of Medicine of the Republic of Korea (South Korea). https://www.medhist.or.kr/kshm/about.php
The management team is as follows
- Journal Manager: CHOI Eun Kyung, Editor-in-Chief of KJMH, Kyungpook National University, Korea
https://www.medhist.or.kr/about/editorial.php
5. Governing body
The governing body is the journal's editorial board.
6. Editorial team and contact information
https://www.medhist.or.kr/about/contact.php
The Editorial team is available from Editorial Board page at the front part of the journal.
Contact information
Editor: CHOI Eun Kyung, Kyungpook National University, Korea
The Korean Society for the History of Medicine
Department of Humanities and Social Medicine, College of Medicine, The Catholic University of Korea
222 Banpo-daero, Seocho-gu, Seoul, Korea (06591)
Tel: +82-2-3147-8306
Email: medhistory@hanmail.net
7. Copyright and licensing
Copyright policy: All published papers become the permanent property of the Korean Society for the History of Medicine. Copyrights of all published materials are owned by the Korean Society for the History of Medicine and permission must be obtained for any commercial use of materials. Every author should sign the copyright transfer agreement forms.
Licensing information: This is an Open Access journal distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
8. Author fees
There is no article processing charge or submission-related fees to author-side until there is a policy change.
9. Process for the identification of and dealing with allegations of research misconduct
https://www.medhist.or.kr/authors/ethics.php
When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (COPE) (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.
10. Publication ethics
Journal policies on authorship and contributorship
https://www.medhist.or.kr/authors/ethics.php
Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, and/or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Every author should meet all of these four conditions. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author.
Corresponding author and first author: Korean Journal of Medical History does not allow multiple corresponding authors for one article. Only one author should correspond with the editorial office and readers for one article. Korean Journal of Medical History does accept notice of equal contribution for the first author when the study was clearly performed by co-first authors.
Correction of authorship after publication: Korean Journal of Medical History does not correct authorship after publication unless a mistake has been made by the editorial staff. Authorship may be changed before publication but after submission when an authorship correction is requested by all of the authors involved with the manuscript.
How the journal will handle complaints and appeals
The policy of the journal is primarily aimed at protecting the authors, reviewers, editors, and the publisher of the journal. If not described below, the process of handling complaints and appeals follows the COPE guidelines available from: https://publicationethics.org/appeals.
Who complains or makes an appeal? Submitters, authors, reviewers, and readers may register complaints and appeals in a variety of cases as follows: falsification, fabrication, plagiarism, duplicate publication, authorship dispute, conflict of interest, ethical treatment of animals, informed consent, bias or unfair/inappropriate competitive acts, copyright, stolen data, defamation, and legal problem. If any individuals or institutions want to inform the cases, they can send a letter via the contact page on our website: https://www.medhist.or.kr//about/contact.php. For the complaints or appeals, concrete data with answers to all factual questions (who, when, where, what, how, why) should be provided.
Who is responsible for resolving and handling complaints and appeals? The Editor, Editorial Board, or Editorial Office is responsible for them. A legal consultant or ethics editor may be able to help with decision making.
What may be the consequence of the remedy? It depends on the type or degree of misconduct. The consequence of resolution will follow the COPE guidelines.
Journal policies on conflicts of interest / competing interests
The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.
Journal policies on data sharing and reproducibility;
https://www.medhist.or.kr/authors/ethics.php
This journal follows the data sharing policy described in "Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors" (https://doi.org/10.3346/jkms.2017.32.7.1051). As of July 1, 2018 manuscripts submitted to ICMJE journals that report the results of interventional clinical trials must contain a data sharing statement as described below. Clinical trials that begin enrolling participants on or after January 1, 2019 must include a data sharing plan in the trial's registration. The ICMJE's policy regarding trial registration is explained at http://www.icmje.org/about-icmje/faqs/clinical-trials-registration/. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record.
All of the authors of research articles that deal with interventional clinical trials must submit data sharing plan of example 1 to 4 in Table 1. Based on the degree of sharing plan, authors should deposit their data after de-identification and report the DOI of the data and the registered site.
Table 1. Examples of data sharing statements that fulfill these ICMJE requirements*
Element |
Example 1 |
Example 2 |
Example 3 |
Example 4 |
Will individual participant data be available (including data dictionaries)? |
Yes |
Yes |
Yes |
No |
What data in particular will be shared? |
All individual participant data collected during the trial, after deidentification. |
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). |
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). |
Not available |
What other documents will be available? |
Study protocol, statistical analysis plan, informed consent form, clinical study report, analytic code |
Study protocol, statistical analysis plan, analytic code |
Study protocol |
Not available |
When will data be available (start and end dates)? |
Immediately following publication. No end date. |
Beginning at 3 months and ending at 5 years following the article publication. |
Beginning at 9 months and ending at 36 months following the article publication. |
Not applicable |
With whom? |
Anyone who wishes to access the data. |
Researchers who provide a methodologically sound proposal. |
Investigators whose proposed use of the data has been approved by an independent review committee (“learned intermediary”) identified for this purpose. |
Not applicable |
For what types of analyses? |
Any purpose |
To achieve aims in the approved proposal. |
For individual participant data meta-analysis. |
Not applicable |
By what mechanism will data be made available? |
Data are available indefinitely at (link to be included). |
Proposals should be directed to xxx@yyy. To gain access, data requestors will need to sign a data access agreement. |
Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. |
Not applicable |
|
|
Data are available for 5 years at a third-party website (link to be included). |
Information regarding submitting proposals and accessing data may be found at (link to be provided). |
|
ICMJE = International Committee of Medical Journal Editors.
*These examples are meant to illustrate a range of, but not all, data sharing options.
Journal's policy on ethical oversight
When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by COPE (http://publicationethics.org/resources/flowcharts). The Editorial Board will discuss the suspected cases and reach a decision. We will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.
Upon discovery of misconduct in research and/or publication ethics, the following actions will be taken: A declaration of manuscript retraction and its reason will be made public via the journal and website and the incident will be shared with the funding agency as applicable, as well as the authors’ institution. A written warning will be issued to authors, who will be banned from submitting manuscripts for a minimum of 3 years. Authors’ membership to the Korean Society for the History of Medicine will also be cancelled.
Journal's policy on intellectual property
All published papers become the permanent property of the Korean Society for Women Health Nursing. Copyrights of all published materials are owned by the Society.
Journal's options for post-publication discussions and corrections
The post-publication discussion is available through ‘Letter to the Editor’. If any readers have a concern on any articles published, they can submit letters to the editor on the articles. If any errors or mistakes in the article are found, it can be corrected through errata, corrigenda, or retraction.
11. Publishing schedule
https://www.medhist.or.kr/about/about.php
Korean Journal of Medical History is published tri-annually in the last day of April, August and December from 2012.
12. Access
https://www.medhist.or.kr/authors/access.php
Korean Journal of Medical History is freely accessible from https://www.medhist.or.kr/authors/access.php according to the Creative Commons License (http://creativecommons.org/licenses/by-nc/4.0/). The copyright, including the right of online transmission, is owned by the Korean Society for the History of Medicine.
13. Archiving
Korean Journal of Medical History is accessible without barrier from Korea Citation Index (https://kci.go.kr) and is archived in the National Library of Korea (http://nl.go.kr) in the event the journal is no longer published.
14. Revenues sources
Revenue sources of journal are from the support of the Korean Society for the History of Medicine, authors’ article processing charge, and the support of the Korean Federation of Science and Technology Societies grant funded by the Korean government (Ministry of Science and ICT).
15. Advertising
Korean Journal of Medical History currently does not operate advertised products or services.
16. Direct marketing
Journal propagation has been done through the journal website and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope. |